Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues

Modern Pathology

Volumn 23, Issue 12, 2010, Pages 1553-1558

  Zeng, Zihua ^a   Zhang, Peng ^a,d   Zhao, Nianxi ^a   Sheehan, Andrea M ^c   Tung, Ching Hsuan ^b   Chang, Chung Che ^a   Zu, Youli ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

anaplastic large cell lymphoma; CD30 expression; classical Hodgkin lymphoma; immunohistochemistry; immunostaining; oligonucleotide aptamer probe; paraffin embedded tissue staining

Indexed keywords

APTAMER; CD30 ANTIGEN; FORMALDEHYDE; PARAFFIN;

ANTIGEN RETRIEVAL; ARTICLE; CLASSICAL HODGKIN LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; TISSUE SECTION; TUMOR CELL;

ANTIGENS, CD30; APTAMERS, NUCLEOTIDE; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; OLIGONUCLEOTIDE PROBES; PARAFFIN EMBEDDING; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION;

EID: 78649703580     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.151     Document Type: Article

References (19)

1. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346:818-822.
2. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-510.
3. Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 1999;45:1628-1650.
4. Brody EN, Gold L. Aptamers as therapeutic and diagnostic agents. J Biotechnol 2000;74:5-13.
5. Hermann T, Patel DJ. Adaptive recognition by nucleic acid aptamers. Science 2000;287:820-825.
6. Blank M, Blind M. Aptamers as tools for target validation. Curr Opin Chem Biol 2005;9:336-342.
7. Mairal T, Ozalp VC, Lozano Sánchez P, et al. Aptamers: molecular tools for analytical applications. Anal Bioanal Chem 2008;390:989-1007.
8. Bunka DH, Stockley PG. Aptamers come of age-at last. Nat Rev 2006;4:588-596.
9. Cerchia L, Hamm J, Libri D, et al. Nucleic acid aptamers in cancer medicine. FEBS Lett 2002;528: 12-16.
10. 0-amino-mod-ified RNA. Nucleic Acids Res 1996;24:3407-3414.
11. Drolet DW, Moon-McDermott L, Romig TS. An enzyme-linked oligonucleotide assay. Nat Biotechnol 1996;14:1021-1025.
12. Ulrich H, Wrenger C. Disease-specific biomarker discovery by aptamers. Cytometry A 2009;75:727-733.
13. Davis KA, Abrams B, Lin Y, et al. Use of a high affinity DNA ligand in flow cytometry. Nucleic Acids Res 1996;24:702-706.
14. 0-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res 1998;26:3915-3924.
15. Mori T, Oguro A, Ohtsu T, et al. RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. Nucleic Acids Res 2004;32:6120-6128.
16. Zhang P, Zhao N, Zeng Z, et al. Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells. Lab Invest 2009;89:1423-1432.
17. Faria M, Ulrich H. Sugar boost: when ribose modifications improve oligonucleotide performance. Curr Opin Mol Ther 2008;10:168-175.
18. Kainz S, Czaja R, Greiner-Stoffele T, et al. Selection of RNase-resistant RNAs. Handb Exp Pharmacol 2006; 173:447-455.
19. Andreola ML, Calmels C, Michel J, et al. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleo-tides. Eur J Biochem 2000;267:5032-5040.